Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Adv Exp Med Biol. 2016;886:171–189. doi: 10.1007/978-94-017-7417-8_9

Table 9.2.

Endometrial carcinoma miRNAs, their expression level, proposed function and transcriptional targets

miRNA Cell/tissue type ↑/↓ Function Proposed target Validationa References
miR-200a/b/c HEC-1A, Ishikawa cell lines Proliferation NAb Yes Lee et al. (2011)
miR-141,
miR-429
miR-200c HEC-1A, Ishikawa cell lines Proliferation BRD7 Yes Park et al. (2012)
miR-9,
miR-27,
Endometrial carcinoma tissue, Ishikawa cells NDc FOXO1 (decreased) ND Myatt et al. (2010)
miR-96,
miR-153,
miR-182,
miR-183,
miR-186 HEC-1B cells Proliferation FOXO1 Yes Myatt et al. (2010)
miR-7,
miR-149,
Endometrial carcinoma tissue ND NA ND Myatt and Lam (2007)
miR-449b,
miR-204
miR-204 HEC-1A cell line Migration, invasion FOXC1 Yes Myatt and Lam (2007)
miR-125b Type II endometrial carcinoma cells Proliferation, invasion (in vitro and in vivo) TP53INP1 Yes Jiang et al. (2011)
a

Target validation was performed by 3″ UTR reporter construct assays and/or, miRNA transfection and Western analysis

b

NA = function or proposed target was not assessed in the cited study

c

ND = not determined